Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
In SUSTAIN-7, a study comparing semaglutide to dulaglutide in patients with inadequately controlled T2DM, a greater reduction in body weight was observed with 0.5 mg semaglutide (4.6 kg, standard error [SE] 0.28) compared with 0.75 mg dulaglutide (2.3 kg, SE 0.27) (estimated treatment difference [ETD] 2.26 kg, 95% CI 3.02 to 1.51
Molecular signature for receptor engagement in the metabolic peptide hormone amylin
Those with kidney disease or heart failure should follow their provider's specific fluid recommendations
Potential Side Effects and Considerations Like other GLP-1s, the most commonly observed side effects were digestive, including nausea, diarrhoea, vomiting, and constipation
US$ 24.25
US$ 27.41
US$ 24.66
